CLINICAL TRIALS IN SLE: WHAT HAVE WE LEARNED?

被引：0
|
作者：
Merrill, J. T. [1 ]
机构：
[1] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [1] What have we learned from clinical neuroprotective trials?
    Morgenstern, LB
    NEUROLOGY, 2001, 57 (05) : S45 - S47
  • [2] What have we learned from clinical trials on prevention?
    Pellicano, R
    Kerr, PG
    Atkins, RC
    KIDNEY INTERNATIONAL, 2005, 67 : S101 - S106
  • [3] Amiodarone: What have we learned from clinical trials?
    Naccarelli, GV
    Wolbrette, DL
    Dell'Orfano, JT
    Patel, HM
    Luck, JC
    CLINICAL CARDIOLOGY, 2000, 23 (02) : 73 - 82
  • [4] A decade of the Clinical Trials Transformation Initiative: What have we accomplished? What have we learned?
    Tenaerts, P.
    Madre, L.
    Landray, M.
    CLINICAL TRIALS, 2018, 15 : 5 - 12
  • [5] What have we learned from recent clinical trials in AD?
    Rosenberg, R.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E482 - E482
  • [6] Stroke trials: What have we learned?
    Madhavan, R
    Jacobs, BS
    Levine, SR
    NEUROLOGICAL RESEARCH, 2002, 24 : S27 - S32
  • [7] Understanding clinical trials: What have we learned from systematic reviews?
    Moore, RA
    PROCEEDINGS OF THE 9TH WORLD CONGRESS ON PAIN, 2000, 16 : 757 - 770
  • [8] Clinical Trials with Retrovirus Mediated Gene Therapy – what Have we Learned?
    Nikolai G. Rainov
    Huan Ren
    Journal of Neuro-Oncology, 2003, 65 : 227 - 236
  • [9] What We Have Learned: The Impact of Quality From a Clinical Trials Perspective
    FitzGerald, Thomas J.
    SEMINARS IN RADIATION ONCOLOGY, 2012, 22 (01) : 18 - 28
  • [10] Clinical trials with retrovirus mediated gene therapy - what have we learned?
    Rainov, NG
    Ren, H
    JOURNAL OF NEURO-ONCOLOGY, 2003, 65 (03) : 227 - 236
12345